Thank you for your interest in this activity.
|
|
|
|
Ocular Pathogen Resistance: Emerging Clinical Data
|
|
Author(s)/Faculty: Marguerite B. McDonald, MD, FACS; Richard L. Abbott, MD; Gary N. Foulks, MD, FACS;
more
Charles B. Slonim, MD, FACS
|
|
Source: OCULAR SURGERY NEWS U.S. EDITION
|
Type: Monograph
|
Number of Articles: 5
|
|
Release Date: June 2009
|
Expiration Date: June 10, 2010
|
Cost: $0.00 / $0.00
|
|
Credit Type: CME
|
Number of Credit(s): 1.00
|
Provider:
|
OVERVIEW
The resistance of ocular pathogens to antibiotics continues to evolve and increase. Notably, resistance to newer generation fluoroquinolones has been shown to develop. This was surprising since they target 2 enzymes, as opposed to the older generation fluoroquinolones, which only have one target. This monograph will review the mechanisms by which bacteria may develop resistance, as well as the resistance patterns of various organisms to various antibiotics. Advice will be given on the proper usage of antibiotics, which can decrease the probability of the development of resistance. New agents on the horizon and clinical trials demonstrating their efficacy and safety will be discussed.
|
- Introduction
- Increasing Levels of Resistance to Topical Antibiotics
- How Do Bacteria Develop Resistance? The Mechanisms and Recommended
Prescribing Strategies Explained
- Novel Fluoroquinolones for the Treatment of Ophthalmic Infections
- Clinical Trials of Topical Antibiotics for Ocular Surface Infection